Various Procedural Treatment Options for Androgenetic Alopecia

Launched by SHEIKH ZAYED MEDICAL COLLEGE · Feb 7, 2025

Keywords

ClinConnect Summary

This clinical trial is studying different treatments for a common type of hair loss called androgenetic alopecia (AGA), which affects many men and is increasingly seen in women. The researchers want to compare the effectiveness of two topical treatments: minoxidil, which helps improve blood flow to hair follicles, and finasteride, which works by blocking a hormone that contributes to hair loss. The goal is to see which treatment works better for growing hair in men aged 20 to 50 who have specific stages of AGA.

To participate in this trial, you need to be a male between 20 and 50 years old with AGA classified as stage 2 to 6. You should not have used any other hair loss treatments in the past month. However, if you have certain scalp issues, a history of hair transplants, or are currently using specific medications, you won't be eligible. If you join the trial, you’ll apply either minoxidil or finasteride to your scalp and help researchers learn more about these treatments. Remember, this trial is not yet recruiting, so you’ll need to wait for it to start before you can sign up.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Age: 20-50 years
• • Gender: Male
• • ANDROGENETIC ALOPECIA with AGA stage 2-6 Norwood-Hamilton -classification
• • Patients not taking any treatment in last 1 month
• Exclusion Criteria:
• • Abrasion or abnormalities to the scalp
• • Hair transplant
• • Hypersensitivity
• • Recent history of local infections of the head
• • History of relevant significant disease active seborrheic dermatitis
• * Concurrent use of :
• • corticosteroids
• • anabolic steroids or over-the-counter 'hair restorers'
• • use of drugs with anti-androgenic properties within 6 months light or laser treatment of the scalp within the last 3 months.